Pharmacokinetics and effects of alfaxalone after intravenous and intramuscular administration to cats

References

• Evans JM, Aspinall KW, Hendy PG. Clinical evaluation in cats of a new anaesthetic, CT 1341. Journal of Small Animal Practice 13, 479–86, 1972 doi: 10.1111/j.1748-5827.1972.tb06874.x
   PubMed Web of Science ®Google Scholar
• Ferré PJ, Pasloske K, Whittem T, Ranasinghe MG, Li Q, Lefebvre HP. Plasma pharmacokinetics of alfaxalone in dogs after an intravenous bolus of Alfaxan-CD RTU. Veterinary Anaesthesia and Analgesia 33, 229–36, 2006 doi: 10.1111/j.1467-2995.2005.00264.x
   PubMed Web of Science ®Google Scholar
• Goodwin WA, Keates HL, Pasloske K, Pearson M, Sauer B, Ranasinghe MG. The pharmacokinetic and pharmacodynamics of the injectable anaesthetic alfaxalone in the horse. Veterinary Anaesthesia and Analgesia 38, 431–8, 2011 doi: 10.1111/j.1467-2995.2011.00634.x
   PubMed Web of Science ®Google Scholar
• Grubb TL, Greene SA, Perez TE. Cardiovascular and respiratory effects, and quality of anesthesia produced by alfaxalone administered intramuscularly to cats sedated with dexmedetomidine and hydromorphone. Journal of Feline Medicine and Surgery 15, 858–65, 2013 doi: 10.1177/1098612X13478265
   PubMed Web of Science ®Google Scholar
• *Heit M, Schnell M, Whittem T, Pasloske K. Safety and efficacy of Alfaxan-CD RTU administered once to cats subcutaneously at 10 mg/kg. Proceedings of the 22nd Annual American College of Veterinary Internal Medicine (ACVIM) Forum. P 432, 2004
   Google Scholar
• Jones KL. Therapeutic review: alfaxalone. Journal of Exotic Pet Medicine 21, 347–53, 2012 doi: 10.1053/j.jepm.2012.09.011
   Web of Science ®Google Scholar
• Lau C, Ranasinghe MG, Shiels I, Keates H, Pasloske K, Bellingham MC. Plasma pharmacokinetics of alfaxalone after a single intraperitoneal or intravenous injection of Alfaxan in rats. Journal of Veterinary Pharmacology and Therapeutics 36, 516–20, 2013 doi: 10.1111/jvp.12055
   PubMed Web of Science ®Google Scholar
• Michou JN, Leece EA, Brearley JC. Comparison of pain on injection during induction of anaesthesia with alfaxalone and two formulations of propofol in dogs. Veterinary Anaesthesia and Analgesia 39, 275–81, 2012 doi: 10.1111/j.1467-2995.2012.00709.x
   PubMed Web of Science ®Google Scholar
• Muir W, Lerche P, Wiese A, Nelson L, Pasloske K, Whitem T. The cardiorespiratory and anaesthetic effects of clinical and supraclinical doses of alfaxalone in cats. Veterinary Anaesthesia and Analgesia 36, 42–54, 2009 doi: 10.1111/j.1467-2995.2008.00428.x
   PubMed Web of Science ®Google Scholar
• O’Hagan BJ, Pasloske K, McKinnon C, Perkins NR, Whittem T. Clinical evaluation of alfaxalone as an anaesthetic induction agent in cats less than 12 weeks of age. Australian Veterinary Journal 90, 395–401, 2012 doi: 10.1111/j.1751-0813.2012.00983.x
   PubMed Web of Science ®Google Scholar
• Pasloske K, Sauer B, Perkins N, Whittem T. Plasma pharmacokinetics of alfaxalone in both premedicated and unpremedicated Greyhound dogs after single, intravenous administration of Alfaxan at a clinical dose. Journal of Veterinary Pharmacology and Therapeutics 32, 510–3, 2009 doi: 10.1111/j.1365-2885.2009.01070.x
   PubMed Web of Science ®Google Scholar
• Rodrigo-Mocholí D, Belda E, Bosmans T, Laredo FG. Clinical efficacy and cardiorespiratory effects of intramuscular administration of alfaxalone alone or in combination with dexmedetomidine in cats. Veterinary Anaesthesia and Analgesia 43, 291–300, 2016 doi: 10.1111/vaa.12304
   PubMed Web of Science ®Google Scholar
• Tamura J, Ishizuka T, Fukui S, Oyama N, Kawase K, Itami T, Miyoshi K, Sano T, Pasloske K, Yamashita K. Sedative effects of intramuscular alfaxalone administered to cats. Journal of Veterinary Medical Science 77, 897–904, 2015 doi: 10.1292/jvms.14-0200
   PubMed Web of Science ®Google Scholar
• Visser S, Smulders C, Gladdines W, Irth H, van der Graaf P, Danhof M. High-performance liquid chromatography of the neuroactive steroids alphaxalone and pregnanolone in plasma using dansyl hydrazine as fluorescent label: application to a pharmacokinetic-pharmacodynamic study in rats. Journal of Chromatography B 745, 357–63, 2000 doi: 10.1016/S0378-4347(00)00296-6
   PubMed Web of Science ®Google Scholar
• Visser S, Smulders C, Reijers B, van der Graaf P, Peletier L, Danhof M. Mechanism-based pharmacokinetic-pharmacodynamic modeling of concentration-dependent hysteresis and biphasic electroencephalogram effects of alphaxalone in rats. Journal of Veterinary Pharmacology and Experimental Therapeutics 302, 1158–67, 2002 doi: 10.1124/jpet.302.3.1158
   PubMed Web of Science ®Google Scholar
• Warne LN, Beths T, Whittem T, Carter JE, Bauquier SH. A review of the pharmacology and clinical application of alfaxalone in cats. The Veterinary Journal 203, 141–8, 2015 doi: 10.1016/j.tvjl.2014.12.011
   PubMed Web of Science ®Google Scholar
• Whittem T, Pasloske KS, Heit MC, Ranasinghe MG. The pharmacokinetics and pharmacodynamics of alfaxalone in cats after single and multiple intravenous administration of Alfaxan at clinical and supraclinical doses. Journal of Veterinary Pharmacology and Therapeutics 31, 571–9, 2008 doi: 10.1111/j.1365-2885.2008.00998.x
   PubMed Web of Science ®Google Scholar
• Zaki S, Ticehurst KE, Miyaki Y. Clinical evaluation of Alfaxan-CD as a intravenous anaesthetic in young cats. Australian Veterinary Journal 3, 82–87, 2009 doi: 10.1111/j.1751-0813.2009.00390.x
   Web of Science ®Google Scholar